Recro Pharma
Earnings Date & Report
Last updated:
Recro Pharma’s last earnings date was on 4 May 2022.
Recro Pharma stock Earnings report, Estimates & History
| 2017-08-10 | -0.53 | -0.46 |
|---|---|---|
| 2017-11-09 | -0.75 | -0.48 |
| 2018-02-27 | -1.03 | -0.63 |
| 2018-05-09 | -0.7 | -0.65 |
| 2018-08-07 | -1.34 | -0.62 |
| 2018-11-07 | -0.7 | -0.64 |
| 2019-02-19 | -0.75 | -1.92 |
| 2019-05-10 | -1.06 | -0.09 |
| 2019-08-08 | -0.42 | -0.13 |
| 2019-11-08 | -0.21 | -0.19 |
| 2020-03-04 | -0.25 | 0.61 |
| 2020-05-11 | -0.03 | -0.33 |
| 2020-08-10 | -0.16 | -0.25 |
| 2020-11-09 | -0.2 | -0.09 |
| 2021-02-26 | -0.22 | -0.48 |
| 2021-05-06 | -0.25 | -0.23 |
| 2021-11-09 | -0.05 | -0.07 |
| 2022-03-01 | -0.07 | -0.04 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Recro Pharma stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 4 May 2022 | N/A | -$0.09 | N/A | 21.41M | N/A | |
| 1 Mar 2022 | Beat | -$0.07 | -$0.04 | 19.42M | 22.30M | Earnings Call Transcript |
| 9 Nov 2021 | Missed | -$0.05 | -$0.07 | 18.04M | 18.23M | Earnings Call Transcript |
| 9 Aug 2021 | N/A | N/A | -$0.06 | 18.01M | 18.01M | Earnings Call Transcript |
| 6 May 2021 | Beat | -$0.25 | -$0.23 | 18.14M | 16.80M | |
| 26 Feb 2021 | Missed | -$0.22 | -$0.48 | 6.69M | 9.91M | Earnings Call Transcript |
| 9 Nov 2020 | Beat | -$0.2 | -$0.09 | 26.90M | 19.28M | |
| 10 Aug 2020 | Missed | -$0.16 | -$0.25 | 9.93M | 15.52M | Earnings Call Transcript |
| 11 May 2020 | Missed | -$0.03 | -$0.33 | 1.97M | 21.77M | Earnings Call Transcript |
| 4 Mar 2020 | Beat | -$0.25 | $0.61 | 7.23M | 17.64M | |
| 8 Nov 2019 | Beat | -$0.21 | -$0.19 | 27.91M | 25.25M | |
| 8 Aug 2019 | Beat | -$0.42 | -$0.13 | 100.98M | 31.25M | Earnings Call Transcript |
| 10 May 2019 | Beat | -$1.06 | -$0.09 | 295.21M | 25.06M | |
| 19 Feb 2019 | Missed | -$0.75 | -$1.92 | 6.94M | 17.78M | Earnings Call Transcript |
| 7 Nov 2018 | Beat | -$0.7 | -$0.64 | 19.99M | 18.28M | Earnings Call Transcript |
| 7 Aug 2018 | Beat | -$1.34 | -$0.62 | 46.98M | 21.73M | Earnings Call Transcript |
| 9 May 2018 | Beat | -$0.7 | -$0.65 | 21.04M | 19.54M | Earnings Call Transcript |
| 27 Feb 2018 | Beat | -$1.03 | -$0.63 | 31.12M | 19.04M | |
| 9 Nov 2017 | Beat | -$0.75 | -$0.48 | 26.73M | 17.11M | |
| 10 Aug 2017 | Beat | -$0.53 | -$0.46 | 19.50M | 16.93M | |
Recro Pharma Earnings report FAQs
When is Recro Pharma's next Earnings date?
The company has not set the next earnings date yet. The latest Recro Pharma's earnings date was on 6 May 2021.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.